• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, November 16, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Higher Inflammatory Markers Linked to Pregnancy Loss

by
November 16, 2026
in Health
Reading Time: 7 mins read
0
Higher Inflammatory Markers Linked to Pregnancy Loss

Higher Inflammatory Markers Linked to Pregnancy Loss

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A retrospective study involving 517 women with unexplained recurrent pregnancy loss found that higher levels of specific hematologic inflammatory markers in the first trimester were associated with an increased likelihood of subsequent pregnancy loss. The research, conducted at the Lanzhou University Second Hospital, evaluated five indices derived from routine complete blood count tests: the neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index (SII), and systemic inflammation response index (SIRI). The study aimed to determine whether these readily available clinical markers could help distinguish between pregnancies that resulted in live birth and those that ended in loss before 24 weeks of gestation.

The cohort consisted of women who had experienced at least two unexplained miscarriages but had no more than two live births. Participants were enrolled between September 2019 and December 2022, with blood samples collected during their first hospital visit at a gestational age of 4 to 8 weeks. The study excluded patients with identified causes for miscarriage, such as chromosomal abnormalities, anatomical uterine defects, autoimmune diseases, thrombotic disorders, endocrine factors, infectious conditions, or male factor infertility. This strict exclusion criteria ensured that the remaining participants represented a population with truly unexplained recurrent pregnancy loss, a condition that affects a significant portion of couples and is associated with substantial psychological distress.

Complete blood count analyses were performed using an automated hematology analyzer, with strict quality control measures in place to ensure the accuracy of the hematological parameters. The derived inflammatory indices integrate information across multiple leukocyte lineages, reflecting the balance between innate immune activation and adaptive immune tolerance. For instance, the NLR reflects the ratio of neutrophils to lymphocytes, while the SII is calculated by multiplying the platelet count by the neutrophil count and dividing by the lymphocyte count. These composite indices are often used as proxies for systemic inflammatory status in clinical settings.

The study categorized participants into two groups based on their pregnancy outcomes: 265 women experienced pregnancy loss, defined as biochemical or clinical pregnancy loss before 24 weeks, while 252 women achieved live birth. Baseline comparisons revealed that the pregnancy loss group had significantly higher neutrophil counts and all five inflammatory indices, along with lower lymphocyte counts, compared to the live birth group. These differences were statistically significant, suggesting a more pro-inflammatory hematologic profile in women who subsequently lost their pregnancies.

In multivariable logistic regression models adjusted for age, body mass index, ethnicity, education, and other clinical factors, higher levels of each inflammatory index were positively associated with pregnancy loss. Specifically, each one-unit increase in NLR was associated with a 3.05-fold higher odds of pregnancy loss. Similarly, each 100-unit increase in SII was associated with a 36% increase in odds, and each one-unit increase in SIRI was associated with a 2.74-fold higher odds. The associations for MLR and PLR were also statistically significant, although the magnitude of the odds ratios was smaller. These findings remained robust after Bonferroni correction for multiple comparisons.

Tertile analyses further demonstrated a dose-response relationship, with participants in the highest tertile of each inflammatory index having significantly higher odds of pregnancy loss compared to those in the lowest tertile. For example, women in the highest NLR tertile had 5.51 times the odds of pregnancy loss compared to the lowest tertile. The dose-response curves suggested monotonic increasing patterns, although potential nonlinearity was noted for PLR and SII. However, threshold effect analyses did not identify statistically significant inflection points for these indices, indicating that the risk increased steadily across the range of values observed.

Receiver operating characteristic (ROC) analysis was used to evaluate the discriminative performance of these markers in distinguishing between pregnancy loss and live birth within the study cohort. The area under the curve (AUC) for NLR was 0.752, indicating acceptable discriminative performance, while the AUC for SII was 0.716. The other indices showed lower discriminative performance, with AUCs ranging from 0.622 for MLR to 0.661 for SIRI. The cutoff values derived from the ROC analyses were 3.19 for NLR and 731.25 for SII. Although these values showed statistically significant discrimination, the authors caution that these results are based on in-sample evaluation and do not support stand-alone clinical decision-making without external validation.

Subgroup analyses by age, education level, ethnicity, and type of pregnancy loss showed broadly consistent associations, with no statistically significant interactions detected. This suggests that the observed relationships between inflammatory markers and pregnancy loss were not driven by specific subgroups within the cohort. The study also noted that the inflammatory indices are mathematically and biologically interdependent, as they are derived from shared complete blood count components. Therefore, the observed associations should be interpreted as converging evidence for elevated systemic inflammation rather than multiple independent findings.

The potential mechanisms underlying these associations involve immune dysregulation and systemic inflammation, which can contribute to implantation failure and disturbances in early placental development. Increased inflammatory markers may reflect a shift toward a pro-inflammatory state, characterized by relative neutrophilia or monocytosis and lymphopenia. This environment may trigger abnormal maternal immune activation, leading to impaired trophoblast invasion and defective vascular remodeling at the maternal-fetal interface. Additionally, aberrant platelet and neutrophil counts may promote a hypercoagulable state and microthrombus formation in placental vessels, further impeding placental function.

Several limitations of the study should be acknowledged. The retrospective design limits causal inference, and residual confounding from unmeasured factors, such as therapeutic interventions, smoking, or asymptomatic infections, cannot be ruled out. The classification of unexplained recurrent pregnancy loss relied on retrospective medical records, which may introduce some misclassification. Furthermore, the reported cutoff values and discriminative performance were derived and evaluated in the same single-center cohort without external validation. The strict exclusion criteria also limit the generalizability of the findings to broader real-world populations.

Despite these limitations, the study provides valuable insights into the potential role of hematologic inflammatory markers in predicting pregnancy loss among women with unexplained recurrent pregnancy loss. The findings suggest that NLR and SII may serve as adjunctive risk markers alongside established clinical factors. However, further prospective multicenter studies with standardized sampling protocols and diverse populations are warranted to externally validate these markers and assess their incremental discriminative value. Until such validation is complete, these indices should not be used for clinical decision-making in isolation.

In conclusion, higher first-trimester levels of CBC-derived inflammatory indices, particularly NLR and SII, were associated with pregnancy loss in this cohort of women with unexplained recurrent pregnancy loss. These markers showed modest in-sample discriminative performance, highlighting their potential utility as indicators of systemic inflammation. Future research should focus on standardizing blood-sampling protocols and validating clinically useful cutoff values in diverse populations to determine whether these indices can provide incremental value beyond existing clinical factors.

The study was conducted in the Department of Reproductive Medicine at the Lanzhou University Second Hospital, where data were collected from outpatient medical records and the hospital information system. The research team included 517 patients who had a history of two or more unexplained miscarriages and no more than two live births. At enrollment, all participants were between 18 and 46 years of age, with a gestational age of 4 to 8 weeks. The study specifically excluded individuals with high-risk factors for miscarriage, such as chromosomal abnormalities, anatomical uterine defects, autoimmune diseases, thrombotic disorders, endocrine factors, infectious conditions, or male factor infertility. Patients who conceived through assisted reproductive technology, had a body mass index greater than 28 kg/m2, or suffered from severe organ diseases were also removed from the analysis. Additionally, those with acute infections or hematological diseases were excluded to prevent these conditions from affecting the hematological parameters measured.

Blood samples were collected during the patients’ first hospital visit using 3 mL K2EDTA anticoagulant tubes. After collection, the samples were gently inverted 5 to 8 times to ensure thorough mixing with the anticoagulant. They were then transported to the laboratory at ambient temperatures between 18°C and 25°C, protected from light and extreme temperatures. All complete blood count analyses were completed within four hours of collection using a Mindray BC-6800 CRP automated hematology analyzer. The laboratory followed a comprehensive quality control program in accordance with ISO 15189:2022 requirements. Internal quality control involved analyzing commercial quality control materials at three concentration levels daily before patient sample testing. External quality assessment was also performed regularly to validate the accuracy and comparability of the CBC results against peer laboratories, with satisfactory performance maintained in all recent cycles.

Pregnancy outcome data were obtained through face-to-face outpatient follow-up and the hospital information system. Pregnancy loss was defined as either a biochemical pregnancy or a clinical pregnancy loss occurring before 24 weeks of gestation. A clinical pregnancy loss was specifically defined as the loss of an intrauterine pregnancy confirmed by ultrasonography or histology before 24 weeks. In contrast, a biochemical pregnancy was defined as a positive urine or serum human chorionic gonadotropin test without ultrasonographic evidence of an intrauterine gestational sac, followed by a spontaneous decline in hCG levels. Live birth was defined as the complete expulsion or extraction of a product of conception that showed any evidence of life, such as breathing, heartbeat, or definite movement of voluntary muscles, irrespective of gestational age. Based on these definitions, participants were categorized into a pregnancy loss group of 265 women and a live birth group of 252 women.

The statistical analysis accounted for the inherent correlations between the inflammatory indices, which are derived from shared complete blood count parameters. To avoid multicollinearity, a hierarchical approach was adopted where each inflammatory index was entered individually into separate logistic regression models rather than simultaneously. The models were adjusted for various baseline characteristics, including age, body mass index, ethnicity, education, age at menarche, age at first pregnancy, gravidity, parity, and the number of previous pregnancy losses. These variables were selected because they represent baseline characteristics determined before inflammatory index measurement and are not considered mediators in the causal pathway. By including these factors, the researchers aimed to minimize confounding from clinically measurable non-mediating factors, thereby enabling a more accurate estimation of the associations between the inflammatory indices and pregnancy loss outcomes.

Subject of Research: Association between first-trimester hematologic inflammatory markers and pregnancy loss in women with unexplained recurrent pregnancy loss.

Article Title: First‐Trimester Hematologic Inflammatory Markers and Pregnancy Loss in Women With Unexplained Recurrent Pregnancy Loss: A Retrospective Study of Associations and Discrimination

Article References: Wang, R., Mu, F., Zhang, W., Wang, K., & Wang, F. (2026). First‐Trimester Hematologic Inflammatory Markers and Pregnancy Loss in Women With Unexplained Recurrent Pregnancy Loss: A Retrospective Study of Associations and Discrimination. Immunity, Inflammation and Disease, 14(11), Article e70535. https://doi.org/10.1002/iid3.70535

Image Credits: AI Generated

DOI: 10.1002/iid3.70535

Keywords: recurrent pregnancy loss, inflammatory markers, NLR, SII, hematologic indices, retrospective study, pregnancy outcomes, immune dysregulation, clinical prediction, obstetrics, First, Trimester

News Source: Harold Sullivan. (November 16, 2026). Higher Inflammatory Markers Linked to Pregnancy Loss. Scienmag.

Tags: clinical predictionFirsthematologic indicesimmune dysregulationinflammatory markersNLRobstetricspregnancy outcomesRecurrent Pregnancy LossRetrospective studySIItrimester
Share12Tweet7Share2ShareShareShare1

Related Posts

Cancer Support Groups Value Digital Referral Platform

Cancer Support Groups Value Digital Referral Platform

November 16, 2026
First-in-Human Trial Validates Novel Amber Liquid Embolic Agent for Peripheral Occlusion

First-in-Human Trial Validates Novel Amber Liquid Embolic Agent for Peripheral Occlusion

November 16, 2026

Probiotics May Ease Allergic Rhinitis Symptoms but High Heterogeneity Weakens Evidence

November 16, 2026

Heavy Metal Exposure Disrupts Cellular Proteostasis and Drives Neurodegenerative Pathology in Models

November 16, 2026

POPULAR NEWS

  • Single-Cell Sequencing Unveils Immune Signatures Linked to Methotrexate Response in Arthritis

    Single-Cell Sequencing Unveils Immune Signatures Linked to Methotrexate Response in Arthritis

    29 shares
    Share 12 Tweet 7
  • CRISPR Gene Editing Yields Non-Browning Bananas to Extend Shelf Life

    29 shares
    Share 12 Tweet 7
  • Rare Pannonibacter Bloodstream Infection in Hemodialysis Patient Resolves After Catheter Removal

    29 shares
    Share 12 Tweet 7
  • Machine Learning Distinguishes Fenugreek Seeds but Exposes Deep Learning Context Flaws

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Review Assesses Biochar Membranes as Sustainable Candidates for Industrial Carbon Dioxide Capture

Stacking Machine Learning Model Detects Toddler Autism Signs With Ninety-Nine Percent Accuracy

Engineered Statistical Features Drive Network Anomaly Detection Over Complex Deep Architectures

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 87 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.